美國家庭壽險 (AFL) 2023 Q4 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • Good day, and welcome to the Aflac Incorporated Fourth Quarter Year-End 2023 Earnings and 2024 Outlook Call. (Operator Instructions)

    各位好,歡迎參加 Aflac Incorporated 2023 年第四季暨全年財報與 2024 年展望電話會議。(接線員指示)

  • Please note, this event is being recorded.

    請注意,本活動將進行錄音。

  • I would now like to turn the conference over to David Young, Vice President of Investor and Rating Agency Relations for Aflac Incorporated. Please go ahead.

    現在我想將電話會議交給 Aflac Incorporated 投資人與評等機構關係副總裁 David Young。請開始。

  • David Young

    David Young

  • Good morning, and welcome. This morning, we will be hearing remarks about earnings for 2023 as well as our outlook for 2024. First, Dan Amos, Chairman, CEO and President of Aflac Incorporated, will provide an overview of our results and operations in Japan and the United States. Then Max Broden, Executive Vice President and CFO of Aflac Incorporated, will provide an update on our financial results and current capital and liquidity as well as our outlook for 2024. These topics are also addressed in the materials we posted with our earnings release and financial supplement on investors.aflac.com.

    各位早安,歡迎各位。今天早上,我們將聽取關於 2023 年盈餘以及 2024 年展望的說明。首先,Aflac Incorporated 董事長、執行長兼總裁 Dan Amos 將就我們在日本與美國的業績與營運提供概覽。接著,Aflac Incorporated 執行副總裁兼財務長 Max Broden 將更新我們的財務結果、目前資本與流動性狀況,以及 2024 年展望。這些主題也已在我們於 investors.aflac.com 隨盈餘新聞稿與財務補充資料一併發布的文件中說明。

  • In addition, Max provided his quarterly video update, which also includes information about the outlook for 2024. We also posted, under financials on the same site, updated slides of investment details related to our commercial real estate and middle market loans.

    此外,Max 提供了他的季度影片更新,其中也包含 2024 年展望相關資訊。我們也在同一網站的「財務」項下發布了更新的投資明細投影片,內容與我們的商用不動產及中型市場貸款相關。

  • For Q&A, we are also joined by Virgil Miller, President of Aflac U.S.; Charles Lake, Chairman and Representative Director, President of Aflac International; Masatoshi Koide, President and Representative Director, Aflac Life Insurance Japan; and Brad Dyslin, Global Chief Investment Officer, President of Aflac Global Investments.

    在問答環節,我們也邀請到 Virgil Miller(Aflac U.S. 總裁)、Charles Lake(Aflac International 董事長兼代表董事、總裁)、小出雅俊(Aflac Life Insurance Japan 總裁兼代表董事),以及 Brad Dyslin(全球投資長、Aflac Global Investments 總裁)一同參與。

  • Before we begin, some statements in this teleconference are forward-looking within the meaning of federal securities laws. Although we believe these statements are reasonable, we can give no assurance that they will prove to be accurate because they are prospective in nature. Actual results could differ materially from those we discuss today. We encourage you to look at our annual report on Form 10-K for some of the various risk factors that could materially impact our results.

    在開始之前,本次電話會議中的部分陳述屬於聯邦證券法所定義的前瞻性陳述。雖然我們相信這些陳述是合理的,但由於其具有前瞻性,我們無法保證其將被證實為準確。實際結果可能與我們今天討論的內容存在重大差異。我們建議各位查閱我們的 Form 10-K 年報,其中列示了可能對我們業績造成重大影響的各項風險因素。

  • As I mentioned earlier, the earnings release is available on investors.aflac.com and includes reconciliations of certain non-U.S. GAAP measures.

    如我先前所提,盈餘新聞稿已發布於 investors.aflac.com,並包含若干非美國 GAAP 衡量指標的調節表。

  • I'll now turn the call over to Dan. Dan?

    現在我把電話交給 Dan。Dan?

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • Thank you, David, and good morning, everyone. We're glad you're joining us.

    謝謝你,David,各位早安。很高興各位加入我們。

  • Reflecting on 2023, it was a very good year. Our management team, employees, sales distribution have continued to work tirelessly as dedicated stewards of our business. This has allowed us to be there for our policyholders when they need us most, just as we promised.

    回顧 2023 年,這是一個非常好的一年。我們的管理團隊、員工以及銷售通路持續不懈地努力,作為我們業務的盡責管理者。這使我們能在保戶最需要我們的時候陪伴在側,正如我們所承諾的。

  • Aflac Incorporated delivered a very strong earnings for the year. Net earnings per diluted share for 2023 were $7.78. Adjusted earnings per diluted share was $6.23. We're the best in the company's history despite the weakening yen and the impact of the reinsurance retrocession late in the fourth quarter.

    Aflac Incorporated 交出全年非常強勁的盈餘表現。2023 年稀釋後每股淨利為 7.78 美元;調整後稀釋後每股盈餘為 6.23 美元。儘管日圓走弱以及第四季末再保險轉分保(retrocession)的影響,這仍是公司史上最佳表現。

  • Beginning with Japan, Aflac Japan generated solid overall financial results in 2023. For the year, total adjusted revenues declined 3.6% to nearly JPY 1.5 trillion, largely reflecting the impacts of reinsurance and paid-up policies. But this was largely offset by a 7.3% decrease in total benefits and adjusted expenses.

    先從日本談起,Aflac Japan 在 2023 年整體財務結果穩健。全年總調整後營收下降 3.6%,至接近 1.5 兆日圓,主要反映再保險與繳清保單(paid-up policies)的影響。但這在很大程度上被總給付與調整後費用下降 7.3% 所抵銷。

  • Pretax adjusted earnings increased 6% to nearly JPY 457 billion for the year. As a result, Aflac Japan produced an extremely strong profit margin of 30.5%. I am pleased with Aflac Japan's 10.9% year-over-year increase in sales, which was largely driven by a 26% increase in cancer insurance sales, with very significant contributions from Japan Post Company and Japan Post Insurance as well as other alliances, Dai-ichi Life and Daido Life.

    全年稅前調整後盈餘成長 6%,至接近 4,570 億日圓。因此,Aflac Japan 產生了極為強勁的 30.5% 利潤率。我很高興 Aflac Japan 銷售額年增 10.9%,主要由癌症保險銷售成長 26% 所帶動,其中日本郵政公司(Japan Post Company)與日本郵政保險(Japan Post Insurance)以及其他合作夥伴(第一生命與大同生命)均有非常顯著的貢獻。

  • As you may recall, Aflac Japan aims to have a product lineup to meet customers' needs during any life stage. Our latest medical insurance is designed to appeal to younger policyholders' basic needs, and older and existing policyholders who want additional or updated coverage.

    各位或許記得,Aflac Japan 的目標是建立一套產品組合,以滿足客戶在任何人生階段的需求。我們最新的醫療保險旨在吸引年輕保戶的基本需求,以及希望增加或更新保障的年長與既有保戶。

  • While our medical insurance sales were off for the year, they increased 6.5% year-over-year in the fourth quarter, following the introduction of our new medical insurance product in mid-September. Similarly, Aflac Japan refreshed ways in child endowment in 2022 as a way of acquiring younger customers and also introducing opportunities to sell our core third sector products to them.

    雖然我們的醫療保險全年銷售下滑,但在 9 月中旬推出新的醫療保險產品後,第四季醫療保險銷售年增 6.5%。同樣地,Aflac Japan 於 2022 年更新了 WAYS 兒童年金(child endowment),以作為吸引年輕客戶的方式,並同時為其導入銷售我們核心第三領域(third sector)產品的機會。

  • Since the launch of our refreshed WAYS product, approximately 80% of our sales are the younger customers below the age of 50. The level of concurrent third sector sales remains above 50%. Given Japan's demographics, our product strategy is to fit the needs of the customers at any stage in life. Acquiring younger customers is critical to our success along with our intense focus on being where the customer wants to buy insurance. We have a broad network of distribution channels including agencies, alliance partners and banks. This reach continually optimizes opportunities to help provide financial protection to the Japanese consumers.

    自我們更新版 WAYS 產品推出以來,約 80% 的銷售來自 50 歲以下的年輕客戶。同時銷售第三領域產品的比例仍維持在 50% 以上。鑑於日本的人口結構,我們的產品策略是滿足客戶在人生各階段的需求。取得年輕客戶對我們的成功至關重要,同時我們也高度聚焦於在客戶想要購買保險的地方提供服務。我們擁有廣泛的通路網絡,包括代理通路、聯盟合作夥伴與銀行。這樣的觸及範圍持續優化各種機會,以協助為日本消費者提供財務保障。

  • We are working hard to support each channel. While the market presents challenges, we expect to reach JPY 67 billion to JPY 73 billion of sales in Japan by the end of 2026.

    我們正努力支持各通路。儘管市場帶來挑戰,我們預期到 2026 年底,日本的銷售額將達到 670 億至 730 億日圓。

  • Turning to the U.S. We also generated strong overall financial results in 2023. Total adjusted revenues increased 2.1% to $6.6 billion. The decline in total net benefits and claims was slightly offset by the increase in adjusted expenses.

    接著談美國。我們在 2023 年同樣取得強勁的整體財務結果。總調整後營收成長 2.1%,至 66 億美元。總淨給付與理賠的下降,部分被調整後費用的增加所抵銷。

  • Pretax adjusted earnings increased 10.4% to an all-time high of $1.5 billion for the year. As a result, Aflac U.S. produced an extremely strong profit margin of 22.7%.

    全年稅前調整後盈餘成長 10.4%,達到創新高的 15 億美元。因此,Aflac U.S. 產生了極為強勁的 22.7% 利潤率。

  • Aflac U.S. sales increased 5% in 2023, which was at the lower end of our expectations. As you know, we've been focused on increasing persistency to grow profitable earned premium. In addition, we continually evaluate new business to ensure that it is profitable.

    Aflac U.S. 2023 年銷售成長 5%,落在我們預期區間的低端。如各位所知,我們一直專注於提升保單持續率(persistency),以成長具獲利性的已賺保費(earned premium)。此外,我們也持續評估新業務,以確保其具備獲利性。

  • During the fourth quarter, we made some tactical decisions to avoid sales opportunities to certain less profitable larger accounts like those of high turnover. At the same time, we focused on updating our products to ensure that our policyholders continue to realize the value of our products provide.

    在第四季,我們做出一些戰術性決策,避免在某些獲利性較低的大型帳戶(例如高流動率的帳戶)上追求銷售機會。同時,我們也專注於更新產品,以確保保戶能持續體會到我們產品所提供的價值。

  • As part of our efforts, we introduced our new cancer protection insurance policy in the second quarter of 2023. Since that time, our cancer insurance have increased nearly 25%. We know that when people experience the value of our products, it increases persistency, which benefits our policyholders and lower our expenses. I believe that the need for the products and the solutions we offer are as strong or stronger than ever before in both Japan and in the United States.

    作為我們努力的一部分,我們在 2023 年第二季推出新的癌症保障保險保單。自那時起,我們的癌症保險銷售已增加近 25%。我們知道,當人們體驗到我們產品的價值時,保單持續率會提高,這將使保戶受益並降低我們的費用。我相信,無論在日本或美國,我們所提供的產品與解決方案之需求都與以往同樣強勁,甚至更強。

  • We are leveraging every opportunity in Avenue to share this message with consumers, particularly given that our products are sold, not bought.

    我們正善用各種機會與管道來傳遞這個訊息給消費者,特別是考量到我們的產品是「被推銷」而非「被主動購買」。

  • As we communicate the value of our products, we know that the strong brand alone is not enough. We must paint a better picture of how our products help address the gap that people face, even when they have major medical insurance. Knowing our products help lift people up when they need us most is something that makes all of us at Aflac very proud and propels us to do more and achieve more.

    在我們溝通產品價值的同時,我們也知道僅靠強勢品牌並不足夠。我們必須更清楚地描繪我們的產品如何協助彌補人們所面臨的保障缺口,即使他們已擁有主要醫療保險。知道我們的產品能在客戶最需要我們的時候扶持他們,讓 Aflac 的每一位同仁都深感自豪,也驅動我們做得更多、達成更多。

  • We continue to reinforce our leading position and build on that momentum. We are confident that the successful execution of our strategy will lead to sales of at least $1.8 billion in the U.S. by the end of 2025.

    我們持續鞏固領先地位並在此動能上再接再厲。我們有信心,成功執行策略將使美國的銷售額在 2025 年底前至少達到 18 億美元。

  • I'd like to end on addressing our ongoing commitment to prudent liquidity and capital management. We have taken proactive steps in recent years to defend our cash flow and deployable capital against a weakening yen.

    最後,我想談談我們對審慎流動性與資本管理的持續承諾。近年來,我們已採取主動措施,以因應日圓走弱對我們現金流與可運用資本(deployable capital)的影響並加以防禦。

  • At the end of 2023, we had nearly $2.8 billion of liquidity at the holding company, which was more than $1 billion over the minimum balance.

    截至 2023 年底,我們控股公司層級的流動性接近 28 億美元,較最低餘額高出超過 10 億美元。

  • As an insurance company, our primary responsibility is to fulfill the promises we make to our policyholders while being responsive to the needs of our shareholders. We remain committed to maintaining strong capital ratios on behalf of our policyholders and balance this financial strength with the tactical capital deployment. We intend to continue prudently managing our liquidity and capital to preserve the strength of our capital and cash flows. This supports both the dividend track record and the tactical share repurchase.

    作為一家保險公司,我們的首要責任是在回應股東需求的同時,履行對保戶所做的承諾。我們仍致力於代表保戶維持強健的資本比率,並在此財務實力與戰術性資本運用之間取得平衡。我們打算持續審慎管理流動性與資本,以維持資本與現金流的強度。這同時支持我們的股利發放紀錄以及戰術性的庫藏股回購。

  • 2023 marked the 41st consecutive year of dividend increases.

    2023年標誌著連續第41年提高股利。

  • We treasure our track record of dividend growth and remain committed to extending it. Last quarter, the Board put us on a path to continue this record when it increased the first quarter of 2024 dividend, 19% to $0.50.

    我們珍視股利成長的紀錄,並仍致力於延續這項紀錄。上一季,董事會在將2024年第一季股利上調19%至每股0.50美元時,讓我們走上持續維持此紀錄的道路。

  • We also remain in the market repurchasing our shares through 2023 at a historically high level of $700 million per quarter. We have remained tactical in our approach to share repurchase, deploying $2.8 billion in capital to repurchase nearly $39 million of our shares in 2023. Combined with dividend, this means we delivered over $3.8 billion back to the shareholders in 2023, while also investing in the growth of our business.

    我們也在2023年持續於市場回購本公司股票,回購規模達到歷史高檔水準,每季7億美元。我們在股票回購上維持策略性作法,於2023年動用28億美元資本回購近3,900萬股本公司股票。加計股利,這表示我們在2023年回饋股東超過38億美元,同時也投資於業務成長。

  • At the same time, we have maintained our position among companies with the highest return on capital and the lowest cost of capital in the industry.

    同時,我們也維持在業界資本報酬率最高、資本成本最低的公司之列。

  • Overall, I think we can say it's been another strong year.

    整體而言,我認為可以說這又是強勁的一年。

  • I'll now turn the program over to Max, who will cover more details of the financial results for this year and provide an outlook for the key drivers of earnings in 2024. Max?

    接下來我將把節目交給Max,他將更詳細說明今年的財務結果,並就2024年獲利的關鍵驅動因素提供展望。Max?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • Thank you, Dan. This morning, I'm going to address our 2023 results before providing an outlook for certain drivers for 2024 that were included in the slides with our earnings materials filed yesterday with our 8-K.

    謝謝你,Dan。今天早上,我將先說明我們2023年的結果,接著就2024年若干驅動因素提供展望;這些內容已包含在我們昨日隨8-K提交之盈餘資料投影片中。

  • Aflac Incorporated delivered very strong earnings for the year as adjusted earnings per diluted share rose 9.9% to $6.23, the highest amount in our company's history. This result included a $0.19 negative impact from foreign currency and variable investment income was $0.14 per share below our long-term return expectations.

    Aflac Incorporated今年交出非常強勁的獲利表現,調整後稀釋每股盈餘成長9.9%至6.23美元,創公司史上新高。此結果包含外幣造成每股0.19美元的負面影響,且變動型投資收益較我們長期報酬預期低每股0.14美元。

  • In addition, our annual results included remeasurement gains of $0.51 per share, a $0.20 per share noneconomic loss in the fourth quarter under U.S. GAAP related to the innovation of a reinsurance treaty with a third party seeded back to the company, and a $0.04 per share write-off of certain capitalized software development costs in the third quarter.

    此外,我們的年度結果包含每股0.51美元的重新衡量利益、在美國GAAP下第四季因與第三方之再保險條約創新(並回種回公司)而產生的每股0.20美元非經濟性損失,以及第三季對部分資本化軟體開發成本的每股0.04美元沖銷。

  • Our liquidity remains strong with unencumbered holding company liquidity being $1 billion above our minimum balance. Likewise, our capital position remains strong and we ended the year with an SMR above 1,100% in Japan.

    我們的流動性仍然強勁,未設質押的控股公司流動性高於最低餘額10億美元。同樣地,我們的資本部位仍然強健,且日本的SMR在年底高於1,100%。

  • At the end of 2023, we estimated our internally modeled ESR to be above 250% and we expect the FSA to provide final guidance on the ESR later in 2024. We also estimated our combined RBC in the U.S. to be greater than 650% at the end of 2023. These are strong capital ratios, which we actively monitor, stress and manage to extend credit cycles as well as external shocks.

    在2023年底,我們估計內部模型計算的ESR高於250%,並預期FSA將於2024年稍晚提供ESR的最終指引。我們也估計2023年底美國合併RBC大於650%。這些都是強健的資本比率;我們會主動監控、壓力測試並加以管理,以延長信用循環並因應外部衝擊。

  • In addition, impairments have remained within our expectations and with limited impact to both earnings and capital.

    此外,減損仍維持在我們的預期範圍內,對獲利與資本的影響有限。

  • Our adjusted leverage remains below our leverage corridor of 20% to 25% at 19.7%. And this will fluctuate with the yen dollar rate, since we hold approximately 2/3 of our debt denominated in yen as part of our enterprise hedging program to protect the economic value of Aflac Japan in U.S. dollar terms.

    我們的調整後槓桿仍低於20%至25%的槓桿區間,為19.7%。且由於我們約有2/3的債務以日圓計價,作為企業避險計畫的一部分,以美元計價保護Aflac Japan的經濟價值,因此該比率將隨日圓兌美元匯率而波動。

  • In 2023, we repurchased $2.8 billion of our own stock and paid a dividend of $245 million in Q4, offering good relative IRR on these capital deployments.

    2023年,我們回購了28億美元自家股票,並於第四季支付2.45億美元股利,這些資本運用提供了良好的相對內部報酬率(IRR)。

  • We will continue to be flexible and tactical in how we manage the balance sheet and deploy capital to drive strong risk-adjusted ROE with a meaningful spread to our cost of capital.

    我們將持續以彈性且策略性的方式管理資產負債表並配置資本,以推動強勁的風險調整後ROE,並相對於資本成本維持具意義的利差。

  • Adjusted book value per share increased 10.1% and the adjusted ROE was 13.8%, an acceptable spread to our cost of capital. I'm also pleased with our continued development of our Bermuda reinsurance platform, which resulted in 3 transactions during 2023. We will continue to utilize this platform to better manage risk and improve the capital efficiency across the enterprise. And we expect these transactions to be part of a serious that will improve our run rate adjusted ROE by 100 to 200 basis points over time, all things being equal.

    調整後每股帳面價值成長10.1%,調整後ROE為13.8%,相對於資本成本具可接受的利差。我也很高興我們持續發展百慕達再保險平台,並在2023年完成3筆交易。我們將持續運用此平台,以更妥善管理風險並提升全企業的資本效率。我們預期這些交易將成為一系列的一部分,在其他條件不變下,隨時間推移可使我們的常態化調整後ROE提升100至200個基點。

  • Overall, we are very pleased with these results, especially when normalizing for onetime items.

    整體而言,我們對這些結果非常滿意,特別是在將一次性項目正常化之後。

  • Turning to Aflac Japan. Its total benefit ratio for the year was 66%, down 140 basis points from the prior year. Throughout the year, we continue to experience favorable actual to expected on our well-priced large and mature in-force block. We estimate the impact from remeasurement gains to be 130 basis points favorable to the benefit ratio in 2023.

    接著談Aflac Japan。其全年總給付比率為66%,較前一年下降140個基點。全年我們持續在定價良好、規模大且成熟的既有保單組合上,呈現實際經驗優於預期。我們估計重新衡量利益對2023年給付比率帶來130個基點的有利影響。

  • Long-term experience trends, as it relates to treatment of cancer and hospitalization have continued to lead to favorable underwriting experience. Persistency remained solid with a rate of 93.4% and was down 70 basis points year-over-year, reflecting elevated lapse as customers updated their cancer and medical coverage with our latest cancer and medical products.

    長期經驗趨勢方面,就癌症治療與住院而言,持續帶來有利的核保經驗。保單持續率維持穩健,為93.4%,年減70個基點,反映客戶在更新其癌症與醫療保障、改投保我們最新的癌症與醫療產品時,解約率上升。

  • Our expense ratio in Japan was 19.8%, down 50 basis points year-over-year, driven primarily by good expense control and to some extent, by expense allowance from reinsurance transactions.

    日本的費用率為19.8%,年減50個基點,主要受惠於良好的費用控管,且部分來自再保險交易的費用補貼。

  • For the full year, total adjusted revenues in yen were down 3.6% to JPY 1.5 trillion. Net earned premiums declined 5.9% to JPY 1.1 trillion, reflecting the impact of reinsurance transactions, paid up policies and deferred profit liability.

    全年以日圓計的總調整後收入下降3.6%至1.5兆日圓。已賺保費淨額下降5.9%至1.1兆日圓,反映再保險交易、繳清保單以及遞延利潤負債的影響。

  • When excluding these 3 factors, net earned premiums declined an estimated 1.7%. On this same basis, we would expect net earned premiums in 2024 to decline 2.5% to 1.5%. When taking into consideration, the impact of reinsurance, paid-up policies and the deferred profit liability reclassification.

    若排除這三項因素,已賺保費淨額估計下降1.7%。在相同基礎下,我們預期2024年的已賺保費淨額將下降2.5%至1.5%。此預期係在考量再保險、繳清保單以及遞延利潤負債重分類的影響後得出。

  • Adjusted net investment income increased 4% to JPY 365.6 billion, as we experienced higher yields on our U.S. dollar-denominated investments and related favorable FX. This was partially offset by transfer of assets due to reinsurance. Pretax earnings were JPY 456.9 billion or 6% higher than a year ago.

    調整後淨投資收益增加4%至3,656億日圓,因我們的美元計價投資收益率較高,且相關匯率(FX)有利。部分被因再保險而移轉資產所抵銷。稅前盈餘為4,569億日圓,較去年增加6%。

  • For 2024, we would expect our well-priced in-force to show greater stability in terms of the benefit ratio, excluding unlockings and to be in the range of 66% to 68%. This is a function of both favorable morbidity experience and improved mix of business.

    展望2024年,我們預期定價良好的既有保單在給付比率方面將更為穩定(不含解鎖),區間約為66%至68%。這反映有利的罹病率經驗以及業務組合改善。

  • With the current trend in revenues, we're actively reducing our expenses. We are taking both tactical efforts as well as more long-term transformational initiatives, and we would expect our expense ratio to be in the range of 19% to 21% going forward.

    在目前收入趨勢下,我們正積極降低費用。我們同時採取策略性措施與較長期的轉型計畫,並預期未來費用率將落在19%至21%的區間。

  • The pretax profit margin for Japan for 2023 was 30.5%, up 280 basis points year-over-year, a very good result. With approximately 30% of the Japan portfolio in U.S. dollar assets, the strength of the U.S. dollar versus the yen has increased the proportion of net investment income as a component of our pretax profit. With a greater contribution to profitability from net investment income in yen terms, our pretax margin is naturally pushed up. In addition, having transitioned to option-based currency hedging, we expect quarterly hedge costs to remain roughly in line with what we experienced in the fourth quarter of 2023.

    日本2023年的稅前利潤率為30.5%,年增280個基點,表現非常好。由於日本投資組合約30%配置於美元資產,美元相對日圓走強,使淨投資收益在稅前利潤中的占比提高。以日圓計,淨投資收益對獲利的貢獻更大,稅前利潤率自然被推升。此外,在轉為以選擇權為基礎的匯率避險後,我們預期每季避險成本將大致與2023年第四季的水準相當。

  • In combination with a lower expected benefit ratio, we expect a pretax profit margin of 29% to 31% in 2024.

    配合較低的預期給付比率,我們預期2024年的稅前利潤率為29%至31%。

  • Turning to Aflac U.S. Our 2023 total benefit ratio came in well below expectations at 42.8%. We estimate that the remeasurement gains impacted the benefit ratio by 500 basis points in 2023. Claims utilization has stabilized. But as we incorporate more recent experience into our reserve models, we unlocked assumptions and released reserves during the year.

    接著談Aflac U.S.。我們2023年的總給付比率為42.8%,明顯低於預期。我們估計重新衡量利益在2023年使給付比率改善500個基點。理賠使用率已趨於穩定。但隨著我們將較近期的經驗納入準備金模型,我們在年度內解鎖假設並釋放準備金。

  • Persistency increased 130 basis points year-over-year to 78.6%. This is a function of poor persistency quarters following out of the metric and stabilization across numerous product categories.

    保單持續率年增130個基點至78.6%。這是因先前持續率較差的季度已退出衡量指標,且多個產品類別的表現趨於穩定。

  • Our expense ratio in the U.S. was 40.6%, up 90 basis points year-over-year, primarily driven by our growth initiatives and higher DAC amortization. We would expect the U.S. expense ratio to decrease over time as these businesses grow to scale and improve their profitability.

    我們在美國的費用率為 40.6%,年增 90 個基點,主要受我們的成長計畫以及較高的 DAC 攤銷所帶動。隨著這些業務規模擴大並提升獲利能力,我們預期美國費用率將隨時間下降。

  • For the full year, total adjusted revenues were up 2.1% to $6.6 billion. Net earned premiums increased 1.9% to $5.7 billion in 2023. Adjusted net investment income increased 8.6% to $820 million, mainly driven by higher yields on both our fixed and floating rate portfolios.

    全年總調整後營收成長 2.1% 至 66 億美元。2023 年淨已賺保費增加 1.9% 至 57 億美元。調整後淨投資收益增加 8.6% 至 8.2 億美元,主要受固定利率與浮動利率投資組合殖利率上升所帶動。

  • Pretax earnings were $1.5 billion or 10.4% higher than a year ago, driven primarily by the lower benefit ratio, which was largely impacted by the third quarter unlock and only partially offset by the higher expense ratio.

    稅前盈餘為 15 億美元,較去年增加 10.4%,主要由較低的給付率所驅動;給付率大幅受到第三季解鎖(unlock)的影響,且僅部分被較高的費用率所抵銷。

  • For 2024, we would expect net earned premium growth to be in the range of 3% to 5%.

    對於 2024 年,我們預期淨已賺保費成長將落在 3% 至 5% 的區間。

  • Profitability for the U.S. segment was solid, with a pretax margin of 22.7%, driven primarily by the remeasurement gains from unlocking.

    美國分部的獲利能力穩健,稅前利潤率為 22.7%,主要受解鎖帶來的重新衡量收益所帶動。

  • Looking forward at 2024, as we grow products with a higher benefit ratio and lower expense ratio, like group life and disability and network dental and vision, you should start to see those changes reflected in our ratios over time. In 2024, we would expect to operate with a benefit ratio in the range of 45% to 47%, and an expense ratio of 38% to 40%. This translates into an expected profit margin of 19% to 21%.

    展望 2024 年,隨著我們擴大給付率較高、費用率較低的產品(例如團體壽險與失能險,以及網絡牙科與視力保險),您將會開始看到這些變化逐步反映在我們的各項比率中。2024 年,我們預期給付率將落在 45% 至 47% 的區間,費用率為 38% 至 40%。這對應的預期利潤率為 19% 至 21%。

  • In our Corporate segment, we recorded a pretax loss of $425 million, compared to a loss of $218 million a year ago, primarily due to higher investment tax credits and the impact of the innovation of our reinsurance treaty with a third party.

    在公司(Corporate)分部,我們錄得稅前虧損 4.25 億美元,較去年虧損 2.18 億美元擴大,主要由較高的投資稅額抵減(investment tax credits)以及我們與第三方再保合約創新所帶來的影響所致。

  • Adjusted net investment income was $54 million lower than last year due to an increased volume of tax credit investments. Higher rates began to earn in and amortized hedge income increased. This tax credit investments impacted the corporate net investment income line for U.S. GAAP purposes negatively by $343 million, with an associated credit to the tax line.

    由於稅額抵減投資規模增加,調整後淨投資收益較去年減少 5,400 萬美元。較高利率開始反映在收益中,且避險收益攤銷增加。就美國 GAAP 而言,這些稅額抵減投資使公司淨投資收益項目負向影響 3.43 億美元,但在稅項列有相對應的抵減。

  • The net impact to our bottom line was a positive $39 million. To date, these investments are performing well and in line with expectations. The impact from the reinsurance innovation was a onetime negative of $151 million.

    對我們最終盈餘的淨影響為正向 3,900 萬美元。截至目前,這些投資表現良好且符合預期。再保創新帶來的一次性負面影響為 1.51 億美元。

  • Overall, we are very pleased with our 2023 results and our outlook for 2024. I'll now turn the call back to David, so we can begin Q&A. David?

    整體而言,我們對 2023 年的結果以及 2024 年的展望感到非常滿意。接下來我把電話交回給 David,讓我們開始問答。David?

  • David Young

    David Young

  • Thank you, Max. (Operator Instructions)

    謝謝你,Max。(接線員指示)

  • Betsy, we will now take the first question.

    Betsy,我們現在開始第一個問題。

  • Operator

    Operator

  • (Operator Instructions) The first question today comes from Tom Gallagher with Evercore ISI.

    (接線員指示)今天第一個問題來自 Evercore ISI 的 Tom Gallagher。

  • Thomas George Gallagher - Senior MD

    Thomas George Gallagher - Senior MD

  • One numbers question and then one on strategy.

    一個數字問題,然後一個策略問題。

  • Just the numbers question. I guess for the last several years, you've had better portfolio yield in Japan being driven by to pivot into USD portfolio. If I look at the last couple of quarters, that seems to be flattening out. So your portfolio yield has been more stable. Can you talk about what's driving that and what it means for 2024 NII in Japan?

    先問數字問題。我想過去幾年,你們日本的投資組合殖利率較佳,主要是因為轉向美元投資組合。如果我看最近幾個季度,這似乎開始趨於平坦,所以你們的投資組合殖利率更穩定了。你能談談是什麼在驅動這個變化,以及這對 2024 年日本的 NII(淨投資收益)意味著什麼嗎?

  • And then, Dan, strategy question is, just given the growth headwinds in Japan, would you guys consider anything more meaningful on M&A strategically to help facilitate growth? I know you haven't really done this in the past, but there does seem to be an element of kind of unavoidable demographic headwind in Japan that you're fighting against here. So curious what you think on strategy there.

    然後 Dan,策略問題是:考量日本的成長逆風,你們是否會在策略上考慮更具意義的併購(M&A)來促進成長?我知道你們過去其實不太做這類事,但日本似乎存在某種不可避免的人口結構逆風,你們正在對抗它。所以想聽聽你對策略面的看法。

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • I'll kick it off and then hand over to Brad and then to Dan for the strategy question.

    我先開頭,接著交給 Brad,然後再交給 Dan 回答策略問題。

  • As it relates to our investment portfolio and net investment income, you're correct in noticing that our net investment income has increased over the last couple of years. A portion of that is driven by our increased allocation to U.S. dollar assets. And I do want to remind you that, that is primarily driven by the view that we have of hedging our economic exposure to the yen as it relates to the overall exposure that we have as a company to the yen throughout like Japan.

    就我們的投資組合與淨投資收益而言,你的觀察沒錯:過去幾年我們的淨投資收益確實有所增加,其中一部分來自我們提高了美元資產配置。我也想提醒你,這主要是基於我們對沖日圓經濟曝險的觀點,因為就公司整體而言,我們在日本等地對日圓有整體曝險。

  • We have now reached what we view to be more of a steady state as it relates to our total U.S. dollar allocation. So from that level, I would expect a stabilization in terms of our total allocation between yen and dollars within the investment portfolio.

    就我們所認為的美元總配置而言,我們現在已達到較接近穩態(steady state)的水準。因此,從這個水準起,我預期投資組合中日圓與美元之間的總配置將趨於穩定。

  • But as it relates to more of an outlook into 2024 for our NII, I'll turn to Brad and he can give you some more color.

    至於 2024 年 NII 的展望,我把問題交給 Brad,他可以提供更多說明。

  • Bradley Eugene Dyslin - Executive VP, Global CIO & President of Aflac Global Investments

    Bradley Eugene Dyslin - Executive VP, Global CIO & President of Aflac Global Investments

  • Yes. The only thing I would add is just to remind you that our new money yield is both a blend of lower yen rates as well as the higher U.S. dollar rates. Most of our deployment is planned for U.S. dollar assets and that is to maintain the balances, as Max just described. But we do still like yen spread products when we can locate acceptable outlets. When that happens, then we will put them in the portfolio and that does result in pulling down the overall reported new money yield just because of the simple math of lower yen rates.

    是的。我唯一想補充的是提醒你,我們的新資金殖利率(new money yield)是較低的日圓利率與較高的美元利率的混合。正如 Max 剛才所描述,我們大部分的資金配置計畫是投向美元資產,以維持平衡。但當我們能找到可接受的投資去處時,我們仍然喜歡日圓利差型產品。當這種情況發生時,我們就會把它們納入投資組合;由於日圓利率較低,單純從數學上看,這會拉低整體揭露的新資金殖利率。

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • And Tom, in regards to strategy, that's been an issue we've had for several years. We feel like that one of the things we are addressing (technical difficulty) cancer or medical product to it by starting them off on an inexpensive savings plan that gets them to participate with us.

    Tom,關於策略,這是我們幾年來一直面臨的問題。我們覺得我們正在處理的其中一件事是(技術問題)癌症或醫療產品,透過讓客戶先從一個便宜的儲蓄計畫開始,讓他們先參與我們的方案。

  • We also continue to look for new product. We have still not found that third product or third leg that we want to find. And we're continuing to try things.

    我們也持續尋找新產品。我們仍然沒有找到我們想要的第三個產品或第三支柱,而我們也在持續嘗試。

  • But I don't know of anyone right now that I would trade places within Japan in terms of distribution and product that we have and believe we can continue to grow our business moving forward. Saying that, we have to be realistic that it is an aging population and it also is a position where it's not the population is declining.

    但就目前而言,在日本的通路與產品方面,我不知道有誰是我願意去交換位置的;我們相信我們可以在未來持續成長我們的業務。話雖如此,我們也必須務實:這是一個人口老化的社會,而且人口也在下降。

  • But all in all, I still believe it's the best market in the country or in the world because of the persistency and our ability to continue to grow it. And so I think you're going to see growth for the next several years. We did lower that number to -- from JPY 80 billion just to be cautious, but we're encouraged.

    但總體而言,我仍然相信這是全國或全世界最好的市場,因為保單持續率以及我們持續成長的能力。因此我認為未來幾年你會看到成長。我們把那個數字從 800 億日圓下調只是為了更審慎,但我們仍然受到鼓舞。

  • Our Japan Post growth and what's gone there continues to do very well, and we've enjoyed our relationship there. It's our existing distribution system that was really hurt, both in the U.S. and Japan, by COVID, but more so in Japan because if you look back at COVID, it really lasted an additional year in Japan. And because our agents are commission-driven, our newer agents, when COVID hit, all of a sudden did not have an opportunity to go out and sell one-on-one. And as we've always said, our products are sold, they're not bought. And so we go out and make those presentations, and we couldn't do it.

    我們在日本郵政(Japan Post)的成長以及那邊的進展持續表現很好,我們也很享受與他們的合作關係。真正受到衝擊的是我們既有的通路系統,在美國與日本都被 COVID 影響,但日本更嚴重,因為回頭看 COVID,在日本其實多持續了一年。而由於我們的業務員是以佣金為主,當 COVID 來襲時,我們較新的業務員突然沒有機會出去做一對一銷售。正如我們一直說的,我們的產品是被銷售出去的,不是被買走的。因此我們需要出去做簡報,但當時做不到。

  • And so people that were normally working for us on a commission basis tried to find other jobs that were salary in nature and that's what we've been fighting, but it is coming back both in the U.S. and Japan, and I'm encouraged by what I'm seeing there.

    因此,原本以佣金方式為我們工作的人,轉而去找性質上是領薪的其他工作,這就是我們一直在努力克服的問題;但它正在回來,美國與日本都是如此,而我對目前看到的情況感到鼓舞。

  • Operator

    Operator

  • The next question comes from Suneet Kamath with Jefferies.

    下一個問題來自 Jefferies 的 Suneet Kamath。

  • Suneet Laxman L. Kamath - Equity Analyst

    Suneet Laxman L. Kamath - Equity Analyst

  • Just a couple on Japan. And the first one, Dan, just gets back to something you're just talking about in terms of the JPY 67 billion to JPY 73 billion sort of target down from the JPY 80 billion. Are you viewing that as sort of just a delay? And that, that JPY 80 billion is ultimately achievable, maybe a year beyond your original target? Just -- I wanted to think about it a little bit longer term.

    有幾個關於日本的問題。第一個,Dan,回到你剛才提到的:目標從 800 億日圓下調到大約 670 億到 730 億日圓。你是否把這視為只是延後?也就是說,800 億日圓最終仍可達成,只是可能比原先目標晚一年?我想從更長期的角度理解一下。

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • Well, I certainly think it's the potential out there. I don't know what year because the COVID with such an anomaly, what I'd like to do is to let our people that are there on the -- Koide or whoever wants to take this particular question can do it. And then I'll follow up if there's any other part you want me to directly address.

    我當然認為那個潛力是存在的。我不知道會是哪一年,因為 COVID 是一個非常異常的事件;我想做的是讓在當地的人來回答——Koide 或者任何想回答這個問題的人都可以先說。然後如果還有其他部分需要我直接回應,我再補充。

  • Masatoshi Koide - President, CEO & Representative Director

    Masatoshi Koide - President, CEO & Representative Director

  • Yes. This is Koide, Aflac Japan.

    是的。我是小出,Aflac 日本。

  • [Interpreted] So let me answer the question.

    [口譯] 那我來回答這個問題。

  • And the reason why we've changed our target from JPY 80 billion to JPY 67 billion to JPY 73 billion was because we knew that it would take a longer time.

    我們之所以把目標從 800 億日圓調整為 670 億日圓、再到 730 億日圓,是因為我們知道這將需要更長的時間。

  • So we do think that we are able to achieve JPY 80 billion if we look beyond 2026 or after.

    因此,如果把時間拉長到 2026 年之後或更往後來看,我們確實認為有能力達成 800 億日圓。

  • Suneet Laxman L. Kamath - Equity Analyst

    Suneet Laxman L. Kamath - Equity Analyst

  • Got it. Okay. All right. And then I just had another question on, I guess, persistency in Japan. If I just think back to Aflac from years ago, it strikes me that part of the reason the persistency was so strong is because you sold at the work site and there just was very little job mobility in Japan so people just kept the products for a long time. And I guess the question is, as you're shifting now to new distribution channels outside of the work site and to a younger population, which seems to be the objective, should we just expect a natural decline in that persistency over time?

    了解。好。那我還有一個問題,應該是關於日本的保單持續率(persistency)。如果回想多年前的 Aflac,我的印象是持續率之所以很強,部分原因是你們在職場通路銷售,而日本的工作流動性很低,所以大家會把產品持有很久。我想問的是,隨著你們現在把重心轉向職場以外的新通路、並以更年輕族群為目標(看起來這是你們的目標),我們是否應該預期持續率會隨時間自然下滑?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • I'll kick it off and I'll let anybody add some commentary to that as well. As we sell to younger customers, that should actually improve the persistency because of the age-based pricing that we have in Japan, there's a very strong incentive to hold on to the product for a long time and maybe even for life. So as you sell into a younger population, that tends to reduce your lapse rates and improve your persistency.

    我先開頭,之後也請其他人補充。當我們銷售給更年輕的客戶時,持續率其實應該會改善,因為日本採用按年齡定價,客戶有很強的誘因長期持有產品,甚至可能終身持有。因此,銷售給更年輕族群通常會降低解約率並提升持續率。

  • Suneet, you are correct to -- when you look at the corporate agencies that you are referring to from the past that, that was -- had very strong persistency overall in that channel. And as that has become a smaller piece of our overall inforce, that have structurally reduced our persistency.

    Suneet,你的觀察是正確的——你提到過去的企業代理通路,該通路整體持續率確實非常強。隨著該通路在我們整體有效保單(inforce)中的占比變小,結構上也拉低了我們的持續率。

  • The other thing I would mention as well is that we have seen an aging of the block. And when you have an aging of the block, that naturally leads to higher lapsation and lower persistency as well. So you hear us talk about that we are trying to reach younger customers, that is partially to sort of fight these sort of long-term trends that we have going on in our inforce block to not only provide coverage and new coverages to the younger population, but also to improve the overall persistency of the block.

    另外我也想提到,我們看到保單組合(block)正在老化。當保單組合老化時,自然會導致更高的解約(lapse)以及更低的持續率。因此你們會聽到我們談到要觸及更年輕的客戶,部分就是為了對抗我們有效保單組合中這些長期趨勢:不僅為年輕族群提供保障與新保障,同時也提升整體保單組合的持續率。

  • All of this is marginal from year-to-year, and it's very slow moving, but it's certainly something that we're watching closely.

    這些變化每年都是邊際性的、推進也很慢,但我們確實在密切關注。

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • Yoshizumi, do you have any comments you'd like to add? Our head of sales in Japan.

    Yoshizumi,你有沒有想補充的?我們日本的銷售主管。

  • Koichiro Yoshizumi - Senior Managing Exec. Officer, Asst. to the Director of Sales & Marketing and Director

    Koichiro Yoshizumi - Senior Managing Exec. Officer, Asst. to the Director of Sales & Marketing and Director

  • [Interpreted] This is Yoshizumi.

    [口譯] 我是 Yoshizumi。

  • And regarding the persistency that was just asked and answered by Max, and as Max answered, by us focusing on young and middle-aged customers, our persistency is going to be higher, and that is our strategy. And that is actually represented by the medical insurance that was just launched on September 19.

    關於剛才提問並由 Max 回答的持續率議題,正如 Max 所說,透過聚焦年輕與中年客戶,我們的持續率會更高,這就是我們的策略。而這也反映在 9 月 19 日剛推出的醫療保險上。

  • And this product is very popular among the young and middle-aged customers whose ages are under 49 or 49 and under.

    這項產品在 49 歲以下(含 49 歲)的年輕與中年客戶之間非常受歡迎。

  • In terms of the number of policy count that we sold to these young and middle-aged customers, we actually saw a 46% increase year-on-year from the time that we launched in September to the end of the year last year. And these customers are for our middle and long-term growth of Aflac Japan, and these are the customers who will be our assets and our treasure going forward.

    就我們賣給這些年輕與中年客戶的保單件數而言,從 9 月推出到去年年底,我們看到年增 46%。這些客戶是 Aflac 日本中長期成長的關鍵,也是未來我們的資產與珍寶。

  • And the actual premiums that are being paid by young and middle-aged customers are lower. And we truly believe that by focusing on these younger customers and increasing these young customers would contribute to stable growth of our company. And at the same time, as I mentioned, the persistency rate will be higher and this is our strategy.

    而年輕與中年客戶所繳交的實際保費較低。我們確實相信,聚焦並增加這些年輕客戶,將有助於公司穩健成長。同時,如我所提,持續率也會更高,這就是我們的策略。

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • I just want to remind you all that the persistency rate is really high. And we can move it up a little bit, move down a little bit, but it is more than we ever dreamed when we first started doing business over there. So we're very pleased with it.

    我想提醒各位,持續率其實非常高。我們可能讓它小幅上升或小幅下降,但它已經遠超過我們當初在那邊開始做生意時所能想像的水準,所以我們非常滿意。

  • So -- but at the same time, we will improve because when you're writing younger people, of course, they'll live longer, and therefore, will be more persistent.

    所以——但同時我們也會改善,因為當你承保的是更年輕的人,當然他們會活得更久,因此保單也會更具持續性。

  • Operator

    Operator

  • The next question comes from Jimmy Bhullar with JPMorgan.

    下一個問題來自 JPMorgan 的 Jimmy Bhullar。

  • Jamminder Singh Bhullar - Senior Analyst

    Jamminder Singh Bhullar - Senior Analyst

  • So first, a question on Japan. And if you think really long term, is it even realistic to assume that the business can grow given that the population shrinking, the population is aging as well? And then versus 10, 20 years ago, there are a lot more companies in the product lines that you're in? So if you could just comment on that, like -- and maybe on your -- the reduction in guidance on sales, how much of that has to do with just Japan taking longer to recover from COVID versus some of these demographic headwinds?

    首先是關於日本的問題。如果從非常長期來看,考量人口在縮減、人口也在老化,假設業務仍能成長是否現實?另外,相較 10、20 年前,你們所在的產品線有更多公司競爭。能否請你們評論一下——以及關於你們下調銷售指引,其中有多少是因為日本從 COVID 復甦需要更久,多少又是因為這些人口結構逆風?

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • Well, my first comment is, you're correct in terms of a competitive environment. But what is in Japan or any other country that isn't competitive. So being competitive is nothing new to us, and something that we are understanding that we have to constantly look for ways to address how we can identify with consumers and show the need for our products even more.

    我第一個評論是,你對競爭環境的看法是正確的。但日本或任何其他國家,哪裡不是競爭激烈呢?所以競爭對我們來說並不新鮮;我們也理解必須持續尋找方法,去因應如何與消費者產生連結,並更清楚地呈現我們產品的必要性。

  • Now don't forget, we've seen copays and deductibles over many years. I don't know when another one will take place or what will happen. But as inflation, even though small in Japan, you have to take that into account, too.

    另外別忘了,多年來我們已經看到自付額(copays)與免賠額(deductibles)的變化。我不知道下一次會在何時發生或會如何演變。但即使日本的通膨不高,你也必須把它納入考量。

  • So remember, our ability to convert and add more premium to existing policyholders always makes a difference and grows our block of business as well, and we especially think that with the younger people. Let me now turn to Japan and let them comment on it.

    所以請記得,我們把既有保戶轉換並增加其保費的能力,總是能帶來差異,也能擴大我們的保單組合;我們尤其認為在年輕族群上更是如此。接下來我把問題交給日本團隊請他們評論。

  • Masatoshi Koide - President, CEO & Representative Director

    Masatoshi Koide - President, CEO & Representative Director

  • Yes. This is Koide, Aflac Japan.

    是的。我是小出,Aflac 日本。

  • [Interpreted] And it is true that Japan is being projected as having declining population. But at the same time, with the advancement of longevity in the 100-year life era, the need to prepare for longevity risk is expected to increase steadily.

    [口譯] 的確,日本被預測人口將會下降。但同時,隨著長壽化進展、進入「百歲人生」時代,為長壽風險做準備的需求預期將穩定增加。

  • And it's also expected that the aging population could increase the medical cost because as you live long, the probability of suffering from cancer and other diseases will increase.

    同時也預期,高齡人口增加可能推升醫療成本,因為活得越久,罹患癌症及其他疾病的機率就會提高。

  • And in Japan, the sustainability of the overall social security system is being discussed. And this would also include medical and nursing care. And this is being questioned, and the discussions are underway within the Japanese government to review how the benefits and burden should be balanced.

    此外,在日本,整體社會保障制度的永續性正在被討論,其中也包含醫療與長照。其可持續性受到質疑,日本政府內部正就福利與負擔應如何平衡展開檢討討論。

  • And given these circumstances, there is a way of thinking about helping themselves or self-help and preparing for the future as people become more aware of the situation. And as a result, although the population may decline, we do think that the third sector market will steadily grow going forward as well.

    在這些情況下,隨著民眾對現況的認知提高,「自助」與為未來做準備的思維也會增加。因此,雖然人口可能下降,我們仍認為第三部門市場未來也將穩健成長。

  • Jamminder Singh Bhullar - Senior Analyst

    Jamminder Singh Bhullar - Senior Analyst

  • Okay. And then on the U.S. business, do you have a better clarity on the tri-agency rule and its potential impact on your sales?

    好的。那關於美國業務,你們對三機構規則(tri-agency rule)及其對銷售的潛在影響,是否有更清楚的掌握?

  • Virgil Raynard Miller - President of Aflac U.S.

    Virgil Raynard Miller - President of Aflac U.S.

  • This is Virgil, good morning from the U.S. We have been working with the tri-agency sales to talk about any potential impact we could see to those selling supplemental into the consumers out there. And we're waiting on a ruling. Thus far, they set a date to be on April 2024, you know and I know that a date may move. However, we remain encouraged that our policies and coverages are relevant regardless if that rule does come through.

    我是 Virgil,從美國向各位道早安。我們一直與三機構銷售端合作,討論這項規則對向消費者銷售補充保險可能帶來的任何影響。我們正在等待裁定。目前他們設定的日期是 2024 年 4 月,你我都知道日期可能會變動。不過,我們仍然受到鼓舞,因為即使該規則真的生效,我們的保單與保障仍具相關性。

  • We looked at our (inaudible) sales from last year. We really didn't see any decline. We remain flat there. And again, regardless, even if there is a rule or not a rule, our coverage is relevant and we're not predicting any major impact going forward.

    我們檢視了去年我們的(聽不清)銷售,並沒有看到任何下滑,基本持平。再者,不論最後有規則或沒有規則,我們的保障都具相關性,我們不預期未來會有任何重大影響。

  • Operator

    Operator

  • The next question comes from Wilma Burdis with Raymond James.

    下一個問題來自 Raymond James 的 Wilma Burdis。

  • Wilma Carter Jackson Burdis - Research Analyst

    Wilma Carter Jackson Burdis - Research Analyst

  • Could you talk a little bit about the outlook for capital generation, and if we should expect anything on an ongoing basis from internal reinsurance opportunities?

    能否談談資本生成(capital generation)的展望,以及我們是否應該預期內部再保機會在未來能持續帶來一些貢獻?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • Wilma, if you think about the total capital generation that we've had recently and also going into 2024, I don't see any significant change to our overall capital generation on an organic basis. That remains in the $2.6 billion to $3 billion range.

    Wilma,如果你看我們最近的整體資本生成,以及展望到 2024 年,我不認為我們在有機基礎上的整體資本生成會有任何顯著變化。仍會維持在 26 億至 30 億美元的區間。

  • On top of that, we know that we have opportunities that we can overtime unlock more capital through utilizing our reinsurance platform, and we intend to do so. We can't necessarily predict exactly when that will happen or what amounts that will be, but you've seen us in the recent past be quite active on that front. So I would expect us to do more. But on a pure, sort of run rate organic basis, I would have pegged our underlying capital generation at $2.6 billion to $3 billion annually.

    除此之外,我們也知道,透過運用我們的再保平台,隨著時間推移我們有機會釋放更多資本,而我們也打算這麼做。我們未必能精準預測何時會發生或金額會是多少,但你們也看到我們在不久前在這方面相當積極。因此我預期我們會做得更多。不過,若以純粹、類似常態化的有機運行率來看,我原本會把我們的基礎資本生成能力估在每年 26 億至 30 億美元。

  • Wilma Carter Jackson Burdis - Research Analyst

    Wilma Carter Jackson Burdis - Research Analyst

  • And could you just talk more about the commercial real estate watch list? It's higher than a lot of the peers, and you guys have taken the key back on a few properties lately. So if you could go into that and what you're seeing there?

    另外,你能否再多談談商用不動產觀察名單(watch list)?它比許多同業都高,而且你們最近也在幾個物件上把鑰匙收回來了。所以如果你能深入說明一下你們在那裡看到的情況會很有幫助。

  • Unidentified Company Representative

    Unidentified Company Representative

  • Sure. I think there's one primary thing related to our watch list relative to our portfolio that makes us different than peers, and that's the fact that the bulk of our exposure is in transitional real estate. Remember, that's a much shorter asset class. It's a much shorter maturity, generally a 3-year term with some options to extend out a fourth and fifth year.

    當然。我認為,相較於同業,我們的觀察名單相對於我們投資組合有一個主要差異點:我們的大部分曝險在於過渡型不動產(transitional real estate)。請記得,這是一種期限更短的資產類別。到期年限通常較短,一般是 3 年期,並附帶可延展到第 4 年與第 5 年的一些選擇權。

  • So because of that, when you have a market downturn and you've got these maturities coming due and the liquidity is as poor as we're seeing in the market today, it naturally creates an elevated watch list and creates an elevated amount of potential foreclosures.

    因此,當市場下行、這些到期日陸續到來,而市場流動性又像我們今天看到的這麼差時,自然就會造成觀察名單偏高,並帶來較高的潛在法拍(foreclosures)數量。

  • Now, we work very closely with our borrowers to address those maturities. We do our best to avoid foreclosure. But if they are not willing to work with us, if they're not willing to reset the loan to reflect current valuations and give us other protections, we are fortunate that we're in a position we can and will foreclose if we think that's the best route to maximize our recoveries.

    目前我們會與借款人非常密切合作來處理這些到期問題。我們會盡最大努力避免法拍。但如果他們不願意與我們合作、不願意重設貸款以反映目前估值並提供我們其他保障,我們很幸運處於一個可以、也會在我們認為那是最大化回收的最佳途徑時進行法拍的立場。

  • We are blessed with a strong capital and liquidity position, which prevents us from being a forced seller here. So I think it's a combination of the nature of our portfolio, having shorter maturities relative to our total exposure. And then the fact that we are much more willing to foreclose and able to foreclose, if we think that's the best route.

    我們擁有強勁的資本與流動性部位,這讓我們不會被迫在此時成為賣方。所以我認為這是多項因素的組合:我們投資組合的性質、相對於總曝險而言到期較短;再加上如果我們認為那是最佳途徑,我們更願意也更有能力進行法拍。

  • Operator

    Operator

  • The next question comes from Elyse Greenspan with Wells Fargo.

    下一個問題來自 Wells Fargo 的 Elyse Greenspan。

  • Elyse Beth Greenspan - Director & Senior Analyst

    Elyse Beth Greenspan - Director & Senior Analyst

  • My first question, going back to just Japan sales guidance. Dan, I know you said you guys are being cautious in lowering the outlook there. But how do we think about -- how should we think about going from the JPY 60.7 billion of sales in '23 to the new JPY 67 billion to JPY 73 billion target? Should we think about that being even -- even over the next few years or maybe a bit more back-ended?

    我的第一個問題回到日本銷售指引。Dan,我知道你說你們在下調那邊展望時採取較保守的態度。但我們該如何看待——我們應該如何看待從 2023 年 607 億日圓的銷售額到新的 670 億至 730 億日圓目標?我們應該把它視為未來幾年更平均的成長,還是可能更偏後段?

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • Japan? Okay. Well, we at this particular time are just evaluating what we think might happen for the next 2 years. And frankly, we've just tried to be conservative and give us some latitude on what would happen. But we have some very positive things coming out in 2024 that we think will drive sales and are encouraged about it and even some things as we're looking to 2025 that will be coming.

    日本?好的。就目前這個時間點,我們只是評估我們認為未來 2 年可能會發生什麼。坦白說,我們只是試著保守一些,並為可能發生的情況保留一些彈性。不過,我們在 2024 年會推出一些非常正面的事項,我們認為將帶動銷售,對此感到鼓舞;而且在我們展望 2025 年時,也會有一些事情即將推出。

  • Let me make sure that Koide or -- they don't want to make any comments in that regard. Koide?

    我確認一下 Koide 或——他們是否不想就此發表任何評論。Koide?

  • Koichiro Yoshizumi - Senior Managing Exec. Officer, Asst. to the Director of Sales & Marketing and Director

    Koichiro Yoshizumi - Senior Managing Exec. Officer, Asst. to the Director of Sales & Marketing and Director

  • Yes. This is Yoshizumi.

    是的。我是 Yoshizumi。

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • Okay, Yoshizumi.

    好的,Yoshizumi。

  • Koichiro Yoshizumi - Senior Managing Exec. Officer, Asst. to the Director of Sales & Marketing and Director

    Koichiro Yoshizumi - Senior Managing Exec. Officer, Asst. to the Director of Sales & Marketing and Director

  • [Interpreted] Okay. Let me answer the question.

    [口譯] 好的。我來回答這個問題。

  • And as Dan mentioned earlier, it is true that COVID has impacted Japan way beyond our expectation. And as a result, the number of solicitors or sales agents have decreased significantly. And even if you were -- even if our agencies are able to hire the sales agents, we were not able to train them.

    如 Dan 先前提到的,COVID 對日本的影響確實遠超出我們的預期。因此,招攬人員或業務代理人的人數大幅減少。即使——即使我們的代理機構能夠招募到業務人員,我們也無法對他們進行培訓。

  • It was not until May last year in Japan that COVID has been reclassified at the same level as with influenza. So we had no choice, but faced really truly difficult situation in sales for a long time.

    直到去年 5 月,日本才將 COVID 重新分類為與流感同等級別。因此,我們別無選擇,只能在很長一段時間內面對真正非常困難的銷售環境。

  • And at the same time, it is also true that it took us quite a bit of time to train those sales agents that have lower skill. But right now, what we are very much focused on is to really recruit and train that the solicitors or sales agents. Otherwise, we will not be able to train and grow those sales agents that are customer-centric.

    同時,培訓技能較低的業務人員也確實花了我們相當多的時間。但目前我們非常聚焦在真正去招募並培訓招攬人員或業務代理人。否則,我們將無法培養並擴大那些以客戶為中心的業務人員隊伍。

  • Aflac sales agents must be those agents that are very welcomed by our customers. What I mean by that is that those sales agents must respond to customers' needs when they solicit policies, but at the same time, when the benefits and claims are paid. And I do believe that it is Aflac's mission to send out these kind of sales agents to the market appropriately. And that is the reason why we have set our sales target relatively conservative.

    Aflac 的業務代理人必須是非常受客戶歡迎的代理人。我的意思是,這些業務人員在招攬保單時必須回應客戶需求,同時在給付保險金與理賠時也要能妥善服務。我確實相信,將這類業務人員適切地送到市場上,是 Aflac 的使命。也正因如此,我們把銷售目標設定得相對保守。

  • And we currently do have recruiting and development and training plan for our future, as Koide mentioned earlier, beyond maybe JPY 80 billion or even more in the future.

    而且,正如 Koide 先前提到的,我們目前也已為未來制定招募、培育與訓練計畫,未來可能超過 800 億日圓,甚至更多。

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • Elyse, I would think about the sales trajectory as being relatively linear, i.e., not back-end loaded.

    Elyse,我會把銷售軌跡視為相對線性,也就是說,不會偏向後段集中。

  • Elyse Beth Greenspan - Director & Senior Analyst

    Elyse Beth Greenspan - Director & Senior Analyst

  • That's helpful, Max. And then my second question, you guys you pointed out, you obviously have a good amount of buffer at the holdco relative to where you've talked about running. How do you think about, I guess, managing that down? And how should we think about the level of potential buybacks in '24?

    這很有幫助,Max。那我的第二個問題是,你們指出你們在控股公司(holdco)層級相對於你們所談到的目標運行水位,顯然有相當程度的緩衝。你們如何看待——我想是——把那個水位管理下降?以及我們應該如何看待 2024 年潛在的庫藏股回購規模?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • So we're obviously operating with a very significant capital levels in all of our subsidiaries at the moment. Over time, I would expect us to operate at slightly lower capital levels in terms of the ratios than where we are today.

    所以我們目前在所有子公司顯然都維持非常顯著的資本水位。隨著時間推移,我預期我們在比率上會以略低於今天的資本水位來運作。

  • I would reflect that in Japan, we are now going through a transition from SMR to ESR. So I wouldn't necessarily make any dramatic changes ahead of that.

    在日本方面,我們正處於從 SMR 轉換到 ESR 的過渡期。因此在那之前,我不一定會做任何劇烈的調整。

  • In the U.S., we are looking to, over time, target in an RBC of closer to 400%, and we have active plans towards drawing that down.

    在美國方面,隨著時間推移,我們希望把 RBC 目標拉近到約 400%,而且我們有積極的計畫來逐步降低到那個水位。

  • At the same time, we have strong capital and liquidity at the holding companies. We always think about where is capital serving us the best at that very point in time, at the same time, making sure that we have capital available for deployment into dividends, buybacks, et cetera.

    同時,我們在控股公司層級也有強勁的資本與流動性。我們一直在思考,在那個時間點資本放在哪裡最能發揮效益;同時也確保我們有可用資本用於股利、回購等等的資本部署。

  • So overall, I would say that our capital plans remain solid. We've got plenty of capital around, and we try to place it where it makes the best use.

    總體而言,我會說我們的資本規劃依然穩健。我們周邊有充足的資本,而我們會努力把它放在最能發揮用途的地方。

  • Operator

    Operator

  • Your next question comes from John B. Barnidge from Piper Sandler.

    下一個問題來自 Piper Sandler 的 John B. Barnidge。

  • John Bakewell Barnidge - MD & Senior Research Analyst

    John Bakewell Barnidge - MD & Senior Research Analyst

  • I had a question of going back to the Japan sales target. I know you put out a press release in December about the Trupanion pet insurance partnership for Japan. Did that pivot remove any sales contribution from the JPY 80 billion assumption? And can you talk...

    我有一個問題回到日本銷售目標。我知道你們在 12 月發布新聞稿,提到與 Trupanion 在日本的寵物保險合作夥伴關係。那次轉向是否從 800 億日圓假設中移除了任何銷售貢獻?以及你能否談談……

  • Daniel Paul Amos - President, Chairman & CEO

    Daniel Paul Amos - President, Chairman & CEO

  • No, it did not.

    沒有,並沒有。

  • John Bakewell Barnidge - MD & Senior Research Analyst

    John Bakewell Barnidge - MD & Senior Research Analyst

  • Okay. Then can you maybe talk about the growth opportunity for that product in the U.S. that was called out in the pivot and commitment to ownership stake?

    好的。那你能否談談在這次轉向中提到、並承諾持有股權的那項產品,在美國的成長機會?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • Pet insurance, we think, has a significant opportunity in the U.S. market because of the very low penetration of the product itself.

    我們認為寵物保險在美國市場有顯著機會,因為該產品本身的滲透率非常低。

  • For Aflac, we act as a distributor where these premiums, claims, et cetera, do not hit our income statement. So it's an opportunity to -- for our distribution to earn additional commissions, so in that sense, it's very positive to Aflac.

    對 Aflac 而言,我們扮演的是通路分銷商的角色,這些保費、理賠等不會進入我們的損益表。因此,這是一個——讓我們的通路賺取額外佣金的機會,所以從這個角度來看,對 Aflac 非常正面。

  • We do, obviously, have an alliance and a partnership with Trupanion that is strong through the equity ownership that we have in the company, and we capture significant economics over time through that equity ownership.

    當然,我們與 Trupanion 之間有穩固的聯盟與合作夥伴關係,這也透過我們在該公司的股權持有而更為強化;而我們也會隨著時間推移,透過這項股權持有取得可觀的經濟利益。

  • Operator

    Operator

  • Your next question comes from Joel Hurwitz with Dowling & Partners.

    下一個問題來自 Dowling & Partners 的 Joel Hurwitz。

  • Joel Hurwitz

    Joel Hurwitz

  • First, a question on U.S. expenses. So the outlook looks to be largely in line with prior year. You've talked in the past on bending the expense curve and getting closer to a mid-30% expense ratio. Can you just provide an update on those expectations and when we should start to see a more significant drop in the expense ratio in the U.S.?

    首先是關於美國費用的問題。看起來展望大致與前一年一致。你們過去談過要讓費用曲線彎折,並讓費用率更接近 30% 中段。你能否更新一下這些預期,以及我們何時應該開始看到美國費用率更顯著的下降?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • So you are starting to see a drop in 2024, and I would expect that to continue. There are 2 forces at play here, both expenses and our revenues. Expenses, we have active plans to improve our expense efficiency and reduce expenses, both from a tactical and transformational standpoint. But also do not disregard the impact from revenues here. So as we have a number of businesses that are not at scale today, they will grow to scale. And when they do that, their expense ratios will drop significantly, and that will improve overall our expense ratio, i.e., push that down.

    因此你開始在 2024 年看到下降,我預期這種趨勢會持續。這裡有兩股力量在發揮作用,分別是費用與我們的收入。在費用方面,我們有積極的計畫來提升費用效率並降低費用,涵蓋戰術性與轉型性的層面。但也不要忽視收入在此的影響。因為我們目前有多項業務尚未達到規模,它們將成長至具規模。當它們達到規模時,其費用率將大幅下降,這將改善我們整體的費用率,也就是把它往下壓。

  • The last piece to all of this is also where is our future growth coming from. It is generally coming from low expense ratio businesses. Predominantly, the group life and disability business that operates at a significantly lower structural expense ratio than the voluntary benefits business.

    這一切的最後一個部分也在於我們未來的成長來自哪裡。一般而言,主要來自費用率較低的業務。以團體壽險與失能保險業務為主,其結構性費用率明顯低於自願性福利業務。

  • So if you take all of that together, we should have a trajectory that is going lower and we would expect to operate in the 35% to 37% over time.

    因此把這些因素綜合起來,我們的走勢應該會持續下降,並且我們預期長期將在 35% 到 37% 的區間運作。

  • Joel Hurwitz

    Joel Hurwitz

  • Okay. Makes sense. And then just on the recapture. Any color on the economic benefit? And then are there other blocks that you could potentially execute something similar on?

    好的。合理。接著關於回收(recapture),能否談談經濟效益?另外,是否還有其他業務區塊可能執行類似的作法?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • So overall, we're very pleased with the economics. The -- in terms of the impact on future run rate results, they're relatively small, but they're obviously favorable. So there's a favorable run rate going forward.

    整體而言,我們對經濟效益非常滿意。——就對未來常態化(run rate)結果的影響而言,幅度相對不大,但顯然是正面的。因此未來的常態化表現是有利的。

  • In terms of the other blocks out there, I do deem that this is -- was the one that we really had out there. I wish we had more than we could do, but this was really the one that we had outstanding.

    至於其他可能的業務區塊,我認為這——這就是我們真正能做的那一塊。我希望還有更多可以做,但這確實是我們唯一仍在外部的那一塊。

  • Operator

    Operator

  • The next question comes from Ryan Krueger with KBW.

    下一個問題來自 KBW 的 Ryan Krueger。

  • Ryan Joel Krueger - MD of Equity Research

    Ryan Joel Krueger - MD of Equity Research

  • First, I just wanted to follow up on the U.S. expense ratio, given that the group products also tend to have higher benefit ratio. So just curious, as you continue -- as you do grow those business lines and the expense ratio comes down, would you expect, ultimately, for the margins in the U.S. is to increase? Or to what extent would that be offset by naturally higher benefit ratios on those products?

    首先,我想追問一下美國的費用率,因為團體產品通常也有較高的給付率(benefit ratio)。所以我想了解,隨著你們持續——隨著你們擴大這些業務線、費用率下降,你們是否預期最終美國的利潤率會提高?或者在多大程度上會被這些產品自然較高的給付率所抵銷?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • So I think that we have been in a structurally low benefit ratio period, which means that over time, I would expect our benefit ratios to increase. And you're right, Ryan, to acknowledge that the mix impact will also push our benefit ratios higher. So we're always going to see that mix impact, impacting both expense ratio and benefit ratios going forward. And that will have a slightly negative impact to the pretax margin going forward because of mix.

    我認為我們目前處於一個結構性偏低的給付率期間,這表示隨著時間推移,我預期我們的給付率會上升。你說得對,Ryan,產品組合的影響也會推升我們的給付率。因此我們未來會一直看到組合效應,同時影響費用率與給付率。由於組合因素,這將對未來的稅前利潤率帶來些微負面影響。

  • I'll kick it over to Virgil Miller to give his comments as well.

    我也把時間交給 Virgil Miller,請他也補充他的看法。

  • Virgil Raynard Miller - President of Aflac U.S.

    Virgil Raynard Miller - President of Aflac U.S.

  • So first, we're not pleased where we sit with the expense ratio. That is absolutely a focus for the U.S. And one of the things we're doing is making sure we have plans that are going to continue to be in that curve, and you'll see that happening over a period of time. And we're basically challenging all of the U.S. leadership to be accountable for that, and it is tied to our little compensation.

    首先,我們對目前的費用率水準並不滿意。這絕對是美國業務的重點之一。我們正在做的一件事,是確保我們有計畫能讓費用率持續沿著那條曲線改善,你們會在一段時間內看到這些進展。我們基本上要求所有美國的領導團隊對此負責,而且這也與我們的部分薪酬掛鉤。

  • Now I'll go step further, though, I mentioned that when we talked about the actual sales growth this year, one of the things we mentioned -- you heard Dan mention earlier, is our strong underwriting discipline. We are making sure that we only put policies and business on the books that actually have better persistency and lower turnover rates with employees.

    我再進一步說,當我們談到今年實際的銷售成長時,我們提到的一點——你們先前也聽 Dan 提到——是我們強而有力的核保紀律。我們確保只把那些具有更佳保單持續率、且員工流動率較低的保單與業務納入帳上。

  • So the underwriting discipline itself will continue to help drive and bend that expense curve and drive up that benefit ratio, along with, as Max mentioned, the continued growth that we're seeing on (inaudible), it would change the overall business mix in the U.S.

    因此,核保紀律本身將持續有助於推動並拉彎那條費用曲線,同時也會推升給付率;此外,如 Max 所提到,隨著我們在(聽不清楚)方面持續成長,也會改變美國整體的業務組合。

  • So just to conclude, it is absolutely a focus for us and that we are confident we've got the right plans in place to start bidding that curve starting next year.

    總結來說,這絕對是我們的重點,我們也有信心已經具備正確的計畫,從明年開始讓那條曲線開始下彎。

  • Ryan Joel Krueger - MD of Equity Research

    Ryan Joel Krueger - MD of Equity Research

  • And then on Japan internal reinsurance, you've done a transaction 2 years in a row. Is there any practical limitation on doing something like that kind of pretty regularly? Or is there anything that would commit your ability to do that?

    另外關於日本的內部再保,你們已連續兩年做了交易。像這樣相當規律地進行,實務上是否有任何限制?或是否有任何因素會限制你們執行的能力?

  • Max Kristian Broden - Executive VP & CFO

    Max Kristian Broden - Executive VP & CFO

  • So Ryan, over time, we would expect that we could see at about 10% of the Aflac Japan balance sheet to Aflac Bermuda. There are no real legal limitations to it, but at the same time, we got to acknowledge any sort of risks associated with internal reinsurance to make sure that we don't overexpose ourselves or we make sure that we can handle everything associated with it.

    Ryan,隨著時間推移,我們預期大約可將 Aflac Japan 資產負債表的約 10% 轉至 Aflac Bermuda。法律上沒有真正的限制,但同時我們也必須認知任何與內部再保相關的風險,確保不會讓自身曝險過度,或確保我們能妥善處理與此相關的一切。

  • So over time, I would expect us to see something like 10%. And to date, we have done about 4%.

    因此長期來看,我預期大概會是 10% 左右。而截至目前,我們已經做了約 4%。

  • Virgil Raynard Miller - President of Aflac U.S.

    Virgil Raynard Miller - President of Aflac U.S.

  • And this is Virgil. Let me just go back to add, when I was talking about being on that curve, that starts this year, in 2024. I just want to make sure you got that. I said next year, but I mean 2024.

    我是 Virgil。我補充一下,剛才我提到沿著那條曲線改善,其實是從今年、也就是 2024 年開始。我只是想確認你有聽清楚。我剛才說明年,但我的意思是 2024 年。

  • Operator

    Operator

  • The next question comes from Josh Shanker with Bank of America.

    下一個問題來自美國銀行(Bank of America)的 Josh Shanker。

  • Joshua David Shanker - MD

    Joshua David Shanker - MD

  • Just a question as to whether or not the yen at JPY 140, JPY 150 to the dollar versus [110], does that change your hedging costs, your desire to hedge the strategy at all in your investment portfolio?

    我想問的是,日圓在 140、150 日圓兌 1 美元,相較於 [110],這是否會改變你們的避險成本、你們的避險意願,或你們在投資組合中的避險策略?

  • Unidentified Company Representative

    Unidentified Company Representative

  • So obviously, the pricing of options will move and that impacts to some extent, the cost of hedging. And so obviously, every input that you would have to the pricing of options would impact that.

    顯然,選擇權的定價會變動,而這在某種程度上會影響避險成本。因此,任何會影響選擇權定價的輸入因素,都會對此造成影響。

  • In terms of the level of the yen, the answer is no. We want to structurally protect the economic exposure we have to the yen. And we do that through the dollar allocation that we have in the general account. We do that through the debt that we issue in yen, and we do that through the forwards that we hold at the holding company, where we are long dollars, short yen. So overall, we do this in order to reduce risk, not necessarily to express an opinion on the yen.

    至於日圓的水準,答案是否定的。我們希望在結構上保護我們對日圓的經濟曝險。我們透過一般帳戶中的美元配置來做到這點;我們透過以日圓發行的債務來做到這點;我們也透過控股公司持有的遠期合約來做到這點,在那裡我們是做多美元、做空日圓。整體而言,我們這麼做是為了降低風險,而不一定是要對日圓表達看法。

  • Now, how we hedge and protect ourselves, we have all these different levers that we can pull, and the cost and return on capital associated with those can vary over time because of the capital markets. So that's why we will then dial up and dial down some of those associated with that. But it's not necessarily associated with the level of the yen-dollar rate. We are not FX traders. We're looking to protect ourselves long term.

    至於我們如何避險與保護自己,我們有各種不同的槓桿可以運用,而這些工具的成本與資本報酬會因資本市場而隨時間變動。因此我們會相應地調高或調低其中一些配置。但這不一定與日圓兌美元匯率的水準有關。我們不是外匯交易員;我們著眼於長期保護自身。

  • Operator

    Operator

  • This concludes our question-and-answer session. I would like to turn the conference back over to David Young for any closing remarks.

    問答環節到此結束。我想把電話會議交回給 David Young,請他做結語。

  • David Young

    David Young

  • Thank you, Betsy, and thank you all for joining us this morning. If you have any additional questions, please reach out to the Investor and Rating Agency Relations team. We will be happy to talk to you then, and we look forward to speaking to you soon. Have a great day.

    謝謝你,Betsy,也謝謝各位今天早上加入我們。如果你們還有任何其他問題,請聯繫投資人與評等機構關係團隊。我們很樂意與各位進一步交流,也期待很快再與各位對話。祝各位有美好的一天。

  • Operator

    Operator

  • The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.

    本次電話會議已結束。感謝各位參與今天的簡報。您現在可以中斷連線。

  • [Portions of this transcript that are marked [Interpreted] were spoken by an interpreter present on the live call.]

    [本逐字稿中標示為 [Interpreted] 的部分,係由現場電話會議中的口譯員所口譯。]